Rosenblatt maintains Dolby Laboratories at Buy, lowers price target to $75 from $80

Rosenblatt kept Dolby Laboratories at Buy but reduced its price target to $75 from $80, a 6.2% cut. The new target suggests a 27.5% upside from the Nov 17 close of $58.82, according to the firm.

Original reporting
Published Nov 18, 2026, 12:32 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 18, 2026, 12:36 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Rosenblatt maintains Dolby Laboratories at Buy, lowers price target to $75 from $80 — source image
Decision brief

The 30-second read

$DLBNeutralLow
01

Why it matters

This is primarily a valuation update rather than a fundamental change, so it is more likely to affect positioning and sentiment than to drive a major repricing by itself.

02

Market read

Traders may adjust expectations for DLB’s valuation upside, but the unchanged Buy rating limits downside conviction.

03

What to watch

The article provides no thesis details for the target reduction, so traders may discount the signal strength versus other analysts’ concurrent views.

Relevance 4/10Novelty 3/10Timing: today, as the analyst note is published

Background

The piece reports an analyst action from Rosenblatt: rating maintained, price target lowered.

Company-level read

Ticker impact

$DLBNeutralMedium confidence
Context

Rosenblatt maintained Dolby Laboratories at Buy and cut its price target to $75 from $80, implying a lower valuation upside versus the prior target.

Expected impact

Likely mild downside bias as traders price in the lower target, partially offset by the unchanged Buy rating.

Evidence & confidence

The article is a single-analyst note with no new company fundamentals, but the explicit target reduction is a direct, tradable input for valuation expectations.

Market effects

Limited read-through to the broader audio/entertainment tech space because it is a single-name target change without new sector data.

No clear regional spillover indicated; this is company-specific analyst commentary.

Minimal global relevance, as the update does not cite international regulatory, supply, or demand changes.

Counterpoint

Because the rating stays at Buy, the market may treat the target cut as routine and focus on other catalysts (earnings, guidance, product news) rather than the PT delta.

Key entities

  • Dolby Laboratories

    Subject of the analyst note, with Buy rating maintained and price target reduced to $75 from $80.

  • Rosenblatt

    Issued the maintained Buy rating and lowered price target.

Related articles

$NVDAMedAI 8/10

Futures Rise As Huang-less Nvidia Beats And Raises, Gold Crashes Below $3,800

US futures rise as Nvidia (NVDA) reports strong earnings and raises guidance, boosting AI-related stocks. Gold drops below $3,800 after Fed Governor Waller's comments. Nvidia's Q4 revenue guidance is $130B vs. estimates of $125B. Premarket movers include TSLA, GOOGL, AMZN, AAPL, META, AVGO, CRWV, AAOI, BLSH, DLB, LOW, SLS, TTWO, TNDM. Fed policy and economic data releases are in focus.

$DLBMed

Dolby Laboratories Q4 Earnings Call Highlights

Dolby Laboratories reported Q4 earnings with Atmos, Vision, and imaging patents revenue growing 18%, surpassing foundational audio. The company expects mid-single-digit declines in foundational audio and similar growth in other segments for fiscal 2027. New CEO Kevin Whitten focuses on AI and recurring revenue. Dolby anticipates Q1 revenue of $285M-$305M and full-year non-GAAP operating expenses of $775M. The company has $713M in cash and no debt, repurchasing $265M in shares in fiscal 2026.

$DLBMedAI 9/10

Dolby Laboratories Profit Advances In Q4

Dolby Laboratories (DLB) reported Q4 earnings of $80.9M ($0.86 per share), up from $49.3M ($0.51 per share) last year. Adjusted earnings were $117.8M ($1.25 per share). Revenue increased 21.7% to $373.5M. The company guided next quarter's EPS to $0.41-$0.56 and revenue to $285M-$305M.